ESC Premium Access

Poster Session 1 - Lipids

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 31 August 2019

Congress Session

15 presentations in this session

Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

Speaker: Professor E. Bruckert (Paris, FR)
Thumbnail

What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?

Speaker: Doctor A. Endo (Izumo, JP)
Thumbnail

Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany

Speaker: Professor I. Ahrens (Cologne, DE)
Thumbnail

Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

Speaker: Doctor O. Kobo (Hadera, IL)
Thumbnail

Low levels of low density lipoprotein cholesterol and cardiovascular, cancer and all-cause mortality outcomes

Speaker: Professor K. Sung (Seoul, KR)
Thumbnail

Effects of personalized therapy-effect predictions on statin treatment decisions by patients and physicians: a three-armed, blinded, randomized controlled trial

Speaker: Ms N. Jaspers (Utrecht, NL)
Thumbnail

An audit of possible familial hypercholesterolaemia in general practice

Speaker: Associate Professor J. Gallagher (Dublin, IE)
Thumbnail

Screening and treatment of familial hypercholesterolemia in a french sample of ambulatory care: a retrospective longitudinal cohort study

Speaker: Professor J. Ferrieres (Toulouse, FR)
Thumbnail

Validation of clinical diagnostic criteria of familial hypercholesterolemia in Japan: evidence from a comprehensive genetic analysis

Speaker: Doctor H. Tada (Kanazawa, JP)
Thumbnail

Lipopolysaccharide-nuclear factor-kappa B pathway and lipoprotein apheresis effects in patients with familial hypercholesterolemia and coronary artery disease

Speaker: Doctor C. Cui (Beijing, CN)
Thumbnail

15 speakers from this session

Professor Eric Bruckert

University Pierre & Marie Curie Paris VI, Paris (France)
3 presentations
0 follower

Doctor Akihiro Endo

Shimane University Faculty of Medicine, Izumo (Japan)
0 follower

Professor Ingo Ahrens

Hospital der Augustinerinnen, Cologne (Germany)
9 presentations
0 follower

Doctor Ofer Kobo

Hillel Yaffe Medical Center, Hadera (Israel)
0 follower

Professor Kichul Sung

Kangbuk Samsung Hospital, Seoul (Korea (Republic of))
0 follower

Ms Nicole Elise Maria Jaspers

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

Associate Professor Joe Gallagher

Conway Institute, Dublin (Ireland)
0 follower

Professor Jean Ferrieres

Toulouse Rangueil University Hospital of Toulouse, Toulouse (France)
0 follower

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)
0 follower

Doctor Chuanjue Cui

, Beijing (China)
0 follower

Doctor Anselm Kai Gitt

Klinikum Ludwigshafen, Ludwigshafen (Germany)
12 presentations
0 follower

Doctor Michael Farkouh

Peter Munk Cardiac Centre, Toronto (Canada)
1 presentation
0 follower

Doctor Abdul Aziz Asbeutah

University of Tennessee, Memphis (United States of America)
0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
1 follower

Mrs Karin Littmann

Karolinska Institute, Stockholm (Sweden)
0 follower

This platform is supported by

logo Novo Nordisk